Mudaliar Uma, Zabetian Azadeh, Goodman Michael, Echouffo-Tcheugui Justin B, Albright Ann L, Gregg Edward W, Ali Mohammed K
Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Division of Endocrinology, Diabetes and Hypertension, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS Med. 2016 Jul 26;13(7):e1002095. doi: 10.1371/journal.pmed.1002095. eCollection 2016 Jul.
The Diabetes Prevention Program (DPP) study showed that weight loss in high-risk adults lowered diabetes incidence and cardiovascular disease risk. No prior analyses have aggregated weight and cardiometabolic risk factor changes observed in studies implementing DPP interventions in nonresearch settings in the United States.
In this systematic review and meta-analysis, we pooled data from studies in the United States implementing DPP lifestyle modification programs (focused on modest [5%-7%] weight loss through ≥150 min of moderate physical activity per week and restriction of fat intake) in clinical, community, and online settings. We reported aggregated pre- and post-intervention weight and cardiometabolic risk factor changes (fasting blood glucose [FBG], glycosylated hemoglobin [HbA1c], systolic or diastolic blood pressure [SBP/DBP], total [TC] or HDL-cholesterol). We searched the MEDLINE, EMBASE, Cochrane Library, and Clinicaltrials.gov databases from January 1, 2003, to May 1, 2016. Two reviewers independently evaluated article eligibility and extracted data on study designs, populations enrolled, intervention program characteristics (duration, number of core and maintenance sessions), and outcomes. We used a random effects model to calculate summary estimates for each outcome and associated 95% confidence intervals (CI). To examine sources of heterogeneity, results were stratified according to the presence of maintenance sessions, risk level of participants (prediabetes or other), and intervention delivery personnel (lay or professional). Forty-four studies that enrolled 8,995 participants met eligibility criteria. Participants had an average age of 50.8 years and body mass index (BMI) of 34.8 kg/m2, and 25.2% were male. On average, study follow-up was 9.3 mo (median 12.0) with a range of 1.5 to 36 months; programs offered a mean of 12.6 sessions, with mean participant attendance of 11.0 core sessions. Sixty percent of programs offered some form of post-core maintenance (either email or in person). Mean absolute changes observed were: weight -3.77 kg (95% CI: -4.55; -2.99), HbA1c -0.21% (-0.29; -0.13), FBG -2.40 mg/dL (-3.59; -1.21), SBP -4.29 mmHg (-5.73, -2.84), DBP -2.56 mmHg (-3.40, 1.71), HDL +0.85 mg/dL (-0.10, 1.60), and TC -5.34 mg/dL (-9.72, -0.97). Programs with a maintenance component achieved greater reductions in weight (additional -1.66kg) and FBG (additional -3.14 mg/dl). Findings are subject to incomplete reporting and heterogeneity of studies included, and confounding because most included studies used pre-post study designs.
DPP lifestyle modification programs achieved clinically meaningful weight and cardiometabolic health improvements. Together, these data suggest that additional value is gained from these programs, reinforcing that they are likely very cost-effective.
糖尿病预防计划(DPP)研究表明,高危成年人减重可降低糖尿病发病率和心血管疾病风险。此前尚无分析汇总在美国非研究环境中实施DPP干预措施的研究中观察到的体重及心血管代谢危险因素变化情况。
在这项系统评价和荟萃分析中,我们汇总了美国在临床、社区和在线环境中实施DPP生活方式改善计划(侧重于通过每周至少150分钟中等强度体育活动和限制脂肪摄入实现适度[5%-7%]体重减轻)的研究数据。我们报告了干预前后体重及心血管代谢危险因素的汇总变化情况(空腹血糖[FBG]、糖化血红蛋白[HbA1c]、收缩压或舒张压[SBP/DBP]、总胆固醇[TC]或高密度脂蛋白胆固醇)。我们检索了2003年1月1日至2016年5月1日期间的MEDLINE、EMBASE、Cochrane图书馆和Clinicaltrials.gov数据库。两名评审员独立评估文章的合格性,并提取有关研究设计、纳入人群、干预计划特征(持续时间、核心及维持课程数量)和结果的数据。我们使用随机效应模型计算每个结果的汇总估计值及相关的95%置信区间(CI)。为检验异质性来源,结果根据是否存在维持课程情况以及参与者的风险水平(糖尿病前期或其他)和干预实施人员(非专业人员或专业人员)进行分层。44项纳入8995名参与者的研究符合合格标准。参与者的平均年龄为50.8岁,体重指数(BMI)为34.8kg/m²,25.2%为男性。平均而言,研究随访时间为9.3个月(中位数12.0个月),范围为1.5至36个月;计划平均提供12.6次课程,参与者平均参加11.0次核心课程。60%的计划提供某种形式的核心课程后维持(通过电子邮件或亲自进行)。观察到的平均绝对变化为:体重-3.77kg(95%CI:-4.55;-2.99),HbA1c-0.21%(-0.29;-0.13),FBG-2.40mg/dL(-3.59;-1.21),SBP-4.29mmHg(-5.73,-2.84),DBP-2.56mmHg(-3.40,1.71),HDL+0.85mg/dL(-0.10,1.60),TC-5.34mg/dL(-9.72,-0.97)。有维持部分的计划在体重(额外减轻-1.66kg)和FBG(额外降低-3.14mg/dl)方面实现了更大幅度的降低。研究结果受到研究报告不完整和纳入研究的异质性影响,并且存在混杂因素影响,因为大多数纳入研究采用前后对照研究设计。
DPP生活方式改善计划在临床上显著改善了体重及心血管代谢健康状况。总体而言,这些数据表明这些计划具有额外价值,进一步证明它们可能具有很高的成本效益。